- Category
- Small (2023-24)
- Udyam number
- UDYAM-TS-09-0009427

About Maxbien Pharma Private Limited
Data last updated:
Maxbien Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 01 September 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24299TG2020PTC143389. Its GSTIN is 36AANCM7513Q1ZP (Telangana).
The company has an authorised share capital of ₹22 Cr and a paid-up capital of ₹10.53 Cr. It is led by directors Dumpa Bharath Reddy and Prabhavathi Dumpa.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹8.19 Cr, a growth of 39% compared to the previous year. For the same year it recorded a net profit of ₹1.83 Cr (net margin 22.3%) and EBITDA of ₹1.84 Cr (EBITDA margin 22.4%). Revenue has declined at a compounded annual rate (CAGR) of 18% over three years.
The company has about 2 employees on its provident fund (EPFO) records.
The company has 4 deals on record (3 rights issues, 1 funding round), with disclosed funding of ₹4.94 Cr; the latest was in April 2022. Its 10 peer companies in the same principal business activity (retail trading) are compared by revenue, 5 larger and 5 smaller; the largest is Captain Moto Private Limited with revenue of ₹8.21 Cr.
Maxbien Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-09-0009427). For more details, the company can be reached via its website maxbienpharma.in.
Company details
Recognitions & Rankings of Maxbien Pharma
Contact details
Maxbien Pharma Private Limited's registered office is in Hyderabad, Telangana. Its website is maxbienpharma.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressII Floor Dwaraka One Plot No 6&7 Survey No 85 Vittal Rao Nagar Madhapur Serilingampall, Y, Hyderabad, Telangana, India – 500081
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Maxbien Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Maxbien Pharma is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Maxbien Pharma Private Limited, buy the company report.
Financials of Maxbien Pharma Private Limited
FY 2025 filings availableMaxbien Pharma Private Limited reported revenue of ₹8.19 Cr (up 39% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 39% in the latest year, though over three years it has declined at a compounded annual rate (CAGR) of 18%. EBITDA rose 171% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.84 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.83 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 22.4% | ||||
| Net Profit Margin | 22.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Maxbien Pharma Private Limited, buy the company report.
Board of directors of Maxbien Pharma Private Limited
Maxbien Pharma has 2 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dumpa Bharath Reddy | Director | 22 May 2021 | 5 Years 5 Months | Current |
| Prabhavathi Dumpa | Director | 01 Jul 2025 | 1 Years 4 Months | Current |
Peer comparison
Maxbien Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Captain Moto Private Limited | ₹8.21 Cr (FY 2025) | 36.0% | Ahmedabad, Gujarat, India | |||
| Rajkali Exim India Private Limited | ₹8.2 Cr (FY 2025) | 134.0% | Varanasi, Uttar Pradesh, India | |||
| Ananda Derivatives Private Limited | ₹8.19 Cr (FY 2017) | 7929.0% | Chennai, Tamil Nadu, India | |||
| Khanduja Sales Private Limited | ₹8.19 Cr (FY 2024) | -58.0% | Bareilly, Uttar Pradesh, India | |||
| Shri Ganpati Ornaments Private Limited | ₹8.19 Cr (FY 2025) | 25.0% | Gurgaon, Haryana, India | |||
| Maxbien Pharma Private Limitedthis company | ₹8.19 Cr (FY 2025) | ₹1.83 Cr | 22.3% | 39.0% | 2 | Hyderabad, Telangana, India |
| Royal Cruisers Private Limited | ₹8.19 Cr (FY 2025) | 8.0% | Jabalpur, Madhya Pradesh, India | |||
| Blendlife India Private Limited | ₹8.19 Cr (FY 2024) | 231.0% | Hyderabad, Telangana, India | |||
| Auro Chemical Industries Private Ltd | ₹8.19 Cr (FY 2025) | 1.0% | Delhi, India | |||
| Chandiwala Sales Private Limited | ₹8.18 Cr (FY 2025) | -10.0% | Dausa, Rajasthan, India | |||
| Avyaan Commotrade Private Limited | ₹8.18 Cr (FY 2020) | 909197.0% | Howrah, West Bengal, India |
To see the full peer comparison of Maxbien Pharma Private Limited, buy the company report.
Auditor
Maxbien Pharma Private Limited is audited by KY AND CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KY AND CO | FY 2023 | 016381S |
Shareholding
The shareholding of Maxbien Pharma Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Maxbien Pharma Private Limited, buy the company report.
Deals & funding
Maxbien Pharma Private Limited has 4 deals on record (3 rights issues, 1 funding round), with disclosed funding of ₹4.94 Cr; the latest was in April 2022.
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Apr 2022 | Rights issue | ₹50 Lakh | Investors: an individual |
| Aug 2021 | Rights issue | ₹4.5 Cr | Investors: SVS Facility Management Services Private Limited , 3 individuals |
| Mar 2021 | Rights issue | ₹75 Lakh | Investors: an individual |
| Jan 2021 | Funding round | ₹4.94 Cr | Investors: SVS Facility Management Services Private Limited , 3 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Maxbien Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Maxbien Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Maxbien Pharma Private Limited has a workforce of 2 employees on its EPFO records as of Mar 2025, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2024-25 | 2 |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 |
To see the full employee and EPFO history of Maxbien Pharma Private Limited, buy the company report.
GST
Maxbien Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AANCM7513Q1ZP | Telangana | Active | 02 Nov 2020 |
To see the full GST registrations and return filing status of Maxbien Pharma Private Limited, buy the company report.
Recent activity
Maxbien Pharma Private Limited has 9 board changes on record since 2020: 2 appointments and 7 cessations. The latest: Prabhavathi Dumpa ceased to be Additional Director on 29 Sep 2025.
Frequently asked questions
Maxbien Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 01 September 2020 (6+ years old) and is registered under CIN U24299TG2020PTC143389.
Maxbien Pharma has 2 current directors:
- Dumpa Bharath Reddy - Director
- Prabhavathi Dumpa - Director
The latest financial statements of Maxbien Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Maxbien Pharma is 36AANCM7513Q1ZP, registered in Telangana.
The CIN (Corporate Identification Number) of Maxbien Pharma is U24299TG2020PTC143389. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Maxbien Pharma was incorporated on 01 September 2020, making it 6+ years old. It is registered with the Registrar of Companies, Hyderabad.
Maxbien Pharma has 4 deals on record (3 rights issues, 1 funding round), with disclosed funding of ₹4.94 Cr; the latest was in April 2022.
The peers of Maxbien Pharma by revenue are Captain Moto Private Limited, Rajkali Exim India Private Limited, Ananda Derivatives Private Limited, Khanduja Sales Private Limited, Shri Ganpati Ornaments Private Limited and 5 more, all in the same principal business activity (retail trading).
Prabhavathi Dumpa ceased to be Additional Director on 29 Sep 2025. Prabhavathi Dumpa was appointed as Director on 01 Jul 2025. Satyanarayana Reddy Goluguri ceased to be Director on 01 Jul 2025. Maxbien Pharma has 9 board changes on record in total.
Yes, Maxbien Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-TS-09-0009427).
Maxbien Pharma can be reached through the website maxbienpharma.in. Its registered office is in Hyderabad, Telangana, India.

